Brainstem anaesthesia following intranasal packing with lignocaine and adrenaline

[...]the possibility of LA toxicity was ruled out. Inadvertent intravascular administration, high volumes or high concentrations used or injections into inflamed tissues may potentiate the systemic uptake of vasoconstrictors along with local anaesthetics and produce toxic manifestations such as hype...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of anaesthesia Vol. 61; no. 12; pp. 1021 - 1023
Main Authors Kurdi, Madhuri S, Sannaboraiah, Sushma K, Bhosale, Raghavendra B, Gasti, Vinod D
Format Journal Article
LanguageEnglish
Published India Medknow Publications and Media Pvt. Ltd 01.12.2017
Medknow Publications & Media Pvt. Ltd
Medknow Publications & Media Pvt Ltd
Wolters Kluwer Medknow Publications
Subjects
Anesthesia
Anesthesiology
Endoscopy
Hypertension
Letters to Editor
Nose
Respiration
Surgery
Ventilators
Online AccessGet full text

Cover

More Information
Summary:[...]the possibility of LA toxicity was ruled out. Inadvertent intravascular administration, high volumes or high concentrations used or injections into inflamed tissues may potentiate the systemic uptake of vasoconstrictors along with local anaesthetics and produce toxic manifestations such as hypertension, tachycardia, tremors, headache, perspiration, palpitations and ventricular arrhythmias. BSA manifests clinically as a wide range of symptoms including aphasia, apnoea, bradycardia, tachycardia, cyanosis, impaired hearing, cardiac arrest, confusion, diaphoresis, dilatation of the contralateral pupil, drowsiness, dysphagia, facial paralysis, gaze palsy, hypertension, loss of consciousness, nausea and vomiting, seizures and shivering.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0019-5049
0976-2817
DOI:10.4103/ija.IJA_568_17